A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder
- Eun Young Kim
- , Se Hyun Kim
- , Hyun Jeong Lee
- , Nam Young Lee
- , Hye Young Kim
- , C. Hyung Keun Park
- , Yong Min Ahn
- Seoul National University
- National Cancer Center Korea
- Inha University
- University of Ulsan
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations